Dongxin Lin

Dr. Dongxin Lin

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in Journal of Global Health
Verified
Journal Article
Open access
DFDazhi Fan
Dazhi Fan
QXQing XIA
Qing XIA
DLDongxin Lin
Dongxin Lin
YMYubo Ma
Yubo Ma
JRJiaming Rao
Jiaming Rao
ZLZheng-ping Liu
Zheng-ping Liu
Cancer is a significant public health challenge, inflicting considerable health and economic strain on individuals, governments, and society [1]. It is the second leading cause of death worldwide, with an estimated 1.9 million new cancer cases and over 0.6 million cancer-related deaths in the USA in 2021 [2]. Nearly half of all new cancer cases […]

21 February 2022 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
GCGengdong Chen
Gengdong Chen
XGXiao-Yan Gou
Xiao-Yan Gou
TPTing-Ting Pang
Ting-Ting Pang
PLPeng-Sheng Li
Peng-Sheng Li
ZZZixing Zhou
Zixing Zhou
ZLZheng-ping Liu
Zheng-ping Liu
Background: Thyroid function is known to be closely linked with type 2 diabetes, but data on the association between thyroid function and gestational diabetes mellitus (GDM) are inconsistent. Methods: A total of 2849 pregnant women were included in this retrospective study. Serum concentrations of thyroid indicators (free tetraiodothyronine, FT4; thyroid-stimulating hormone, TSH; and thyroid peroxidase antibody, TPO Ab) were obtained from a clinical laboratory. The presence of GDM were drawn from medical records. The clinical subtypes of thyroid function (euthyroidism, subclinical hypothyroidism, hyperthyroidism, and isolated hypothyroxinemia) were categorized according to the thresholds of the 2.5th/97.5th and 10th/90th percentiles of TSH and FT4 concentrations. A concentration of > 34 IU/L was defined as indicating TPO Ab-positivity. Results: Two hundred and thirty-five (8.25%) of the 2849 women were TPO Ab-positive. Higher serum concentrations of FT4 (top vs. bottom tertiles) was found to be negatively associated with the risk of GDM. The corresponding odds (OR) values (top tertile vs. bottom tertile) were 0.71 [95% confidence interval (CI): 0.54, 0.93]. No significant associations were observed between the extremely 2.5th/97.5th or 10th/90th percentiles of FT4 concentration, TSH concentration, thyroid function subtypes (vs. euthyroidism), TPO Ab-positivity (vs. -negativity), and the GDM risk. The corresponding results remained similar when TPO Ab-positive subjects were excluded. Conclusions: A negative association with the risk of GDM was observed for the highest FT4 concentrations tertile. No significant associations were found between the TSH concentration, thyroid function subtypes, TPO Ab positivity, and the GDM risk.

31 August 2020 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
DLDongxin Lin
Dongxin Lin
PLPengsheng Li
Pengsheng Li
DFDazhi Fan
Dazhi Fan
GCGengdong Chen
Gengdong Chen
SWShuzhen Wu
Shuzhen Wu
ZLZheng-ping Liu
Zheng-ping Liu

1 June 2021 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
HZHuishan Zhang
Huishan Zhang
PLPengsheng Li
Pengsheng Li
DFDazhi Fan
Dazhi Fan
SWShuZhen Wu
ShuZhen Wu
JRJiaming Rao
Jiaming Rao
ZLZheng-ping Liu
Zheng-ping Liu
Background: The management of poor sleep during pregnancy is important for maternal and foetal health. The aim of the present study was to investigate the prevalence of poor sleep quality and risk factors for poor sleep during different trimesters of pregnancy for better management of sleep during pregnancy. Methods: A cross-sectional study was conducted among pregnant women in Foshan Women’s and Children’s Hospital. In total, 2281 pregnant women were analysed, and the Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality. Cluster logistic regression was used to analyse the risk factors for poor sleep among all participants, and logistic regression models were built to identify potential risk factors for poor sleep quality in different trimesters of pregnancy. Results: Over half of the participants reported poor sleep quality (51.8%). The rate of poor sleep was lowest in the second trimester. Women who were unmarried had > 12 years of education, exercised < 3 days/week, were in the third trimester, had a high level of nausea and vomiting during pregnancy (NVP) and had a history of infertility had a higher risk of poor sleep. Pregnancy-related factors contributed most to poor sleep. In the first trimester, the main risk factors for poor sleep were a history of infertility and a high level of NVP. In the second trimester, only a high level of NVP was a risk factor for poor sleep. In the last trimester, the risk factors for poor sleep were more education years, exercise < 3 days/week and high levels of NVP. Conclusion: The prevalence and risk factors for poor sleep were different in different trimesters. Clinicians should screen and address poor sleep prior to the first and, especially, the third trimester of pregnancy. Management of poor sleep should be consistent throughout pregnancy and be adjusted in different trimesters.

1 July 2021 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
JRJiaming Rao
Jiaming Rao
DFDazhi Fan
Dazhi Fan
ZZZixing Zhou
Zixing Zhou
XLXin Luo
Xin Luo
HMHuiting Ma
Huiting Ma
ZLZheng-ping Liu
Zheng-ping Liu
Background: To compare the maternal and neonatal outcomes of placenta previa (PP) with and without coverage of a uterine scar in Foshan, China. Methods: A retrospective cohort study comparing all singleton pregnancies with PP was conducted at a tertiary, university-affiliated medical center from 1 January 2012 to 31 April 2017 in Foshan, China. Demographic, clinical and laboratory data were extracted from electronic medical records (EMRs). Maternal and neonatal outcomes of PP with and without coverage of a uterine scar were compared by statistical method. Results: There were 58,062 deliveries during the study period, of which 726 (1.25%) were complicated PP in singleton pregnancies and were further classified into two groups: the PP with coverage of a uterine scar group (PPCS, n=154) and the PP without coverage of a uterine scar group (Non-PPCS, n=572). Overall, premature birth (< 37 weeks, 67.5% vs 54.8%; P=0.019), cesarean section (100% vs 97.6%; P=0.050), intraoperative blood loss > 1000 mL (77.9% vs 16.0%; P< 0.001) or > 3000mL (29.9% vs 3.0%; P< 0.001), bleeding within 2-24 hours after delivery (168.2± 370.1 ml vs 49.9± 58.4 ml; P< 0.001), postpartum hemorrhage (48.7% vs 15.7%; P< 0.001), transfusion (34.6% vs 16.1%; P< 0.001), hemorrhage shock (7.8% vs 1.9%; P< 0.001), hysterectomy (2.6% vs 0.5%; P=0.019), fetal distress (35.7% vs 12.1%; P< 0.001) and APGAR score at 1 min (15.2% vs 7.1%; P=0.002) had a significant difference between PPCS group and Non-PPCS group. After grouping by whether complicated with placenta accreta spectrum disorders (PASD), we found that PPCS was significant associated with more intraoperative blood loss > 1000mL, intraoperative blood loss > 3000mL, bleeding within 2– 24 hours after delivery and fetal distress than the Non-PPCS group. Conclusion: The PPCS group had poorer maternal and neonatal outcomes than the Non-PPCS group after grouping by whether pregnancies complicated with PASD or with different placental positions.

19 January 2024 in Journal of Global Health
Verified
Journal Article
Open access
DFDazhi Fan
Dazhi Fan
DLDongxin Lin
Dongxin Lin
JRJiaming Rao
Jiaming Rao
PLPengsheng Li
Pengsheng Li
GCGengdong Chen
Gengdong Chen
ZLZheng-ping Liu
Zheng-ping Liu
Placental anomalies are associated with several adverse foetal-neonatal and maternal complications. They have three principal types: placenta previa (PP), placenta accreta spectrum disorders (PAS), and vase previa (VP) [1]. According to existing systematic reviews, the prevalence of placental anomalies has been increasing over the past two decades due to the growing incidence of assisted reproductive […]